These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901 [TBL] [Abstract][Full Text] [Related]
4. Characterization of tumor microvascular structure and permeability: comparison between magnetic resonance imaging and intravital confocal imaging. Reitan NK; Thuen M; Goa PE; de Lange Davies C J Biomed Opt; 2010; 15(3):036004. PubMed ID: 20615006 [TBL] [Abstract][Full Text] [Related]
5. Comparison of single- and dual-tracer pharmacokinetic modeling of dynamic contrast-enhanced MRI data using low, medium, and high molecular weight contrast agents. Orth RC; Bankson J; Price R; Jackson EF Magn Reson Med; 2007 Oct; 58(4):705-16. PubMed ID: 17899608 [TBL] [Abstract][Full Text] [Related]
6. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights. Cheng HL; Wallis C; Shou Z; Farhat WA J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents. Henderson E; Sykes J; Drost D; Weinmann HJ; Rutt BK; Lee TY J Magn Reson Imaging; 2000 Dec; 12(6):991-1003. PubMed ID: 11105041 [TBL] [Abstract][Full Text] [Related]
8. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720 [TBL] [Abstract][Full Text] [Related]
9. Novel Epac fluorescent ligand reveals distinct Epac1 vs. Epac2 distribution and function in cardiomyocytes. Pereira L; Rehmann H; Lao DH; Erickson JR; Bossuyt J; Chen J; Bers DM Proc Natl Acad Sci U S A; 2015 Mar; 112(13):3991-6. PubMed ID: 25829540 [TBL] [Abstract][Full Text] [Related]
10. Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI. Hectors SJ; Jacobs I; Lok J; Peters J; Bussink J; Hoeben FJ; Keizer HM; Janssen HM; Nicolay K; Schabel MC; Strijkers GJ Cancer Res; 2018 Mar; 78(6):1561-1570. PubMed ID: 29317433 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous evaluation of vascular morphology, blood volume and transvascular permeability using SPION-based, dual-contrast MRI: imaging optimization and feasibility test. Kwon HJ; Shim WH; Cho G; Cho HJ; Jung HS; Lee CK; Lee YS; Baek JH; Kim EJ; Suh JY; Sung YS; Woo DC; Kim YR; Kim JK NMR Biomed; 2015 Jun; 28(6):624-32. PubMed ID: 25865029 [TBL] [Abstract][Full Text] [Related]
12. Cerebral blood perfusion deficits using dynamic susceptibility contrast MRI with gadolinium chelates in rats with post-ischemic reperfusion without significant dynamic contrast-enhanced MRI-derived vessel permeabilities: A cautionary note. Jin S; Kang M; Cho H PLoS One; 2018; 13(7):e0201076. PubMed ID: 30044884 [TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4. Fruytier AC; Magat J; Neveu MA; Karroum O; Bouzin C; Feron O; Jordan B; Cron GO; Gallez B NMR Biomed; 2014 Nov; 27(11):1403-12. PubMed ID: 25323069 [TBL] [Abstract][Full Text] [Related]
14. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation. Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796 [TBL] [Abstract][Full Text] [Related]
15. Compound 49b Regulates ZO-1 and Occludin Levels in Human Retinal Endothelial Cells and in Mouse Retinal Vasculature. Jiang Y; Liu L; Steinle JJ Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):185-189. PubMed ID: 28114578 [TBL] [Abstract][Full Text] [Related]
16. Critical role for Epac1 in inflammatory pain controlled by GRK2-mediated phosphorylation of Epac1. Singhmar P; Huo X; Eijkelkamp N; Berciano SR; Baameur F; Mei FC; Zhu Y; Cheng X; Hawke D; Mayor F; Murga C; Heijnen CJ; Kavelaars A Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3036-41. PubMed ID: 26929333 [TBL] [Abstract][Full Text] [Related]
17. An extended vascular model for less biased estimation of permeability parameters in DCE-T1 images. Nejad-Davarani SP; Bagher-Ebadian H; Ewing JR; Noll DC; Mikkelsen T; Chopp M; Jiang Q NMR Biomed; 2017 Jun; 30(6):. PubMed ID: 28211961 [TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis. Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065 [TBL] [Abstract][Full Text] [Related]
19. Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques. Calcagno C; Lobatto ME; Dyvorne H; Robson PM; Millon A; Senders ML; Lairez O; Ramachandran S; Coolen BF; Black A; Mulder WJ; Fayad ZA NMR Biomed; 2015 Oct; 28(10):1304-14. PubMed ID: 26332103 [TBL] [Abstract][Full Text] [Related]
20. Validation of Blood Volume Fraction Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscle. Hindel S; Söhner A; Maaß M; Sauerwein W; Möllmann D; Baba HA; Kramer M; Lüdemann L PLoS One; 2017; 12(1):e0170841. PubMed ID: 28141810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]